Search Within

Sean McCarthy Devlin

Formats
  1. Meeting Abstract (375)
  2. Journal Article (219)
  3. Research Letter (16)
  4. Correspondence (5)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Biostatistics Service (617)
  2. Epidemiology and Biostatistics (617)
  3. Department of Medicine (588)
  4. Hematologic Malignancies, Division of (587)
  5. Center for Hematologic Malignancies (585)
  6. Bone Marrow Transplant (470)

More Groups

People
  1. Sergio Giralt (380)
  2. Miguel-Angel Perales (303)
  3. Gunjan Shah (187)
  4. Molly Maloy (162)
  5. Parastoo Dahi (161)
  6. Michael Scordo (152)

More People

Years
  1. 2025 (19)
  2. 2024 (35)
  3. 2023 (52)
  4. 2022 (42)
  5. 2021 (36)
  6. 2020 (56)

More Years

Publications
  1. Blood (204)
  2. Biology of Blood and Marrow Transplantation (133)
  3. Bone Marrow Transplantation (51)
  4. Blood Advances (28)
  5. Transplantation and Cellular Therapy (25)
  6. Journal of Clinical Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (232)
  2. Elsevier Inc. (176)
  3. Nature Publishing Group (74)
  4. American Society of Clinical Oncology (16)
  5. Taylor & Francis Group (16)
  6. American Association for Cancer Research (12)

More Publishers

Results (617)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiple copies of MLL is the most commonly detected cytogenetic abnormality in newly diagnosed multiple myeloma and may modify disease risk
    Meeting Abstract

    Landry, C.; Londono, D.; Devlin, S. M.; Lesokhin, A.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; Jhanwar, S. C.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed multiple myeloma and high-risk cytogenetics permits long-lasting remissions in the absence of graft-versus-host disease
    Meeting Abstract

    Koehne, G.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S.
    Blood (2013)

    Fulltext@MSK | Save
  • Outcomes in patients with acute lymphoblastic leukemia in first or second complete remission receiving ex-vivo T-cell depleted or unmodified allografts: Comparison of results at two institutions
    Meeting Abstract

    Hobbs, G. S.; Hilden, P.; Hamdi, A.; Goldberg, J. D.; Poon, M.; Ledesma, C.; Devlin, S.; Rondon, G.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Mutational profiling of myeloid malignancies for prediction of disease relapse following allogeneic stem cell transplantation
    Meeting Abstract

    Hanash, A. M.; Devlin, S. M.; Maloy, M.; Knapp, K. M.; Miller, V. A.; Lipson, D.; Stephens, P. J.; Otto, G. A.; Yelensky, R.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Higher mycophenolic acid (MPA) trough levels result in lower day 100 severe acute GVHD without increased toxicity in double-unit cord blood transplantation (CBT) recipients
    Meeting Abstract

    Harnicar, S. J.; Ponce, D. M.; Gregornik, D.; Mathew, S.; Evans, K. L.; Zheng, J.; Devlin, S.; Pozotrigo, M.; Scaradavou, A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Prospective evaluation of alternative donor availability in 708 patients: Improved allograft access with enlarging CB inventory for all patients including racial and ethnic minorities
    Meeting Abstract

    Dahi, P. B.; Ponce, D. M.; Byam, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Gonzales, A. M. R.; Sideroff, M.; Wells, D.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy
    Meeting Abstract

    Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)
    Meeting Abstract

    Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.; Castro-Malaspina, H.; Koehne, G.; Ponce, D. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • CD99 is a therapeutic target on disease stem cells in acute myeloid leukemia and the myelodysplastic syndromes
    Meeting Abstract

    Chung, S. S.; Tavakkoli, M.; Devlin, S. M.; Park, C. Y.
    Blood (2013)

    Fulltext@MSK | Save
  • Stem cell transplant versus chemotherapy in older adults with acute myelogenous leukemia in first remission
    Meeting Abstract

    Berman, E.; Maloy, M.; Devlin, S. M.; Papadopoulos, E. B.; Jakubowski, A. A.
    Blood (2013)

    Fulltext@MSK | Save